Unilever plans to expand its research and development presence in India, with investments reported by multiple outlets in the €35–€40 million range. The funding is presented as support for innovation activities across Unilever’s India hubs, including product development and broader “bio-futures” work.
Several outlets describe India as a key location for Unilever’s global R&D strategy and link the decision to India’s role in innovation. The Economic Times and Business Line focus on a €35 million figure and emphasize AI capabilities, including experimentation and automation. NDTV also highlights technology-led R&D, describing planned use of AI-powered tools such as predictive modelling and digital twins. The Hindu frames the announcement as both R&D expansion and an opportunity tied to bio-futures innovation.
Together, the coverage largely agrees on the purpose—strengthening Unilever’s India R&D—and on the general technology direction. The main differences are the reported investment amount and the degree to which outlets foreground AI tools versus bio-innovation themes.
